#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arterial tortuosity syndrome Thalassaemia Sickle cell disease Intracranial calcification Neuroendocrine cell hyperplasia of infancy Sjogren's syndrome Adenocarcinoma gastric Waldenstrom's macroglobulinaemia Infection in an immunocompromised host Congenital ectodermal dysplasia Plasma cell myeloma refractory Small intestine leiomyosarcoma Ventricular tachycardia Pemphigus HER2 gene amplification More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Bronchopulmonary dysplasia – Treatment SAPHO syndrome – Diagnostics Haemophilia A without inhibitors Hepatic angiosarcoma – Treatment Uterine leiomyosarcoma – Treatment Paroxysmal nocturnal haemoglobinuria – Basic Information X-linked lymphoproliferative syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Buserelin Acetate Empasiprubart Metoprolol Succinate Levoleucovorin Gsk4527226 Omalizumab ZELENECTIDE PEVEDOTIN Petrelintide Paracetamol ADCE-D01 Olopatadine Hydrochloride Ddcart‐Cd19 GT-002 ANX007 IDP-121 Nivolumab Pamiparib Naproxen [18F]-Altanserin Eo2317 More therapies…

    Learn about Your Condition

    Vertebrobasilar stroke Ear discomfort Merycism Endometrial stromal sarcoma Macular telangiectasia Endocarditis enterococcal Peritoneal abscess Breast neoplasm High-grade B-cell lymphoma Acute respiratory failure Mantle cell lymphoma recurrent Hepatocellular carcinoma Drug use disorder Osteonecrosis of jaw Dermatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Safety and Effectiveness of Repotrectinib for Patients with ROS1-Positive Non-Small Cell Lung Cancer and Active Brain Metastasis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Metastases to central nervous system
    • Non-small cell lung cancer
    Investigated Drugs:
    • Repotrectinib
    Austria Germany Spain

  • Study on Steroid and Rivaroxaban Treatment for Deep Vein Thrombosis in Behçet’s Syndrome Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Behcet’s syndrome
    Investigated Drugs:
    • Rivaroxaban
    France

  • Study on the Safety and Effectiveness of ProTrans for Treating Type 1 Diabetes in Children and Adolescents

    Recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Protrans
    Sweden

  • Study of ABTL0812, Irinotecan, and Temozolomide for Children with Relapsed or Refractory Neuroblastoma and Other Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    • Neoplasm
    Investigated Drugs:
    • Sodium 2-Hydroxylinoleate
    • Irinotecan
    • Temozolomide
    Spain

  • A study comparing medium-chain triglycerides and sodium chloride infusions during hemodialysis to improve toxin removal in patients with chronic kidney disease

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Soya Oil
    • Triglycerides, Medium Chain
    • Sodium Chloride
    France

  • Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Daunorubicin, Mitoxantrone, and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Fludarabine Phosphate
    • Mitoxantrone
    • Daunorubicin Hydrochloride
    Belgium Denmark Finland The Netherlands Norway Spain +1
Previous Page
1 … 416 417 418 419 420 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!